The explosive growth in mAb-based biologics, the globalization of biomanufacturing, and the economic pressures to reduce capital investment, cost of development and cost of goods all point to changes in how biopharmaceutical manufacturing plants are designed, built and operated.  Join us as we review the main drivers of change, learn from adopters of transformative technologies, evaluate risk landscapes and collaborate to help set the standards for modern bioprocessing. 

  

AGENDA

09:00

Registration

09:50

Welcome and Overview

10:00

Towards Flexible Single-use Biomanufacturing: Key Technologies Needed and Lessons Learned
Adam Goldstein, Principal Scientist, Global Manufacturing Sciences, Roche (Genentech)

10:45

Economic Impact of Adopting Single-use TFF Flat Sheet Cassettes
Brent Van Rite and Stephanie Wickham, Cytovance Biologics

11:15

Break

11:30

Simplifying and Intensifying Upstream Cell Culture

12:00

Lunch and Networking

13:00

Conversion of Adhesion Cell Line to Suspension Perfusion
Matt Zustiak, Manager, Cell Culture Development Group, Patheon Biologics

13:30

Accelerating Downstream Process Development Using Small-scale Automated Purification
Brian O'Mara, Senior Scientist, Biologics Process Development Group, Bristol Myers Squibb

14:00

Break

14:15

Pre-packed Chromatography Column Technologies

14:45

Positive Impact of Pre-packed Columns in a Multi-product Manufacturing Facility
David Briggs, Scientist, Process Sciences, AVID Bioservices

15:15 Panel Discussion and Q&A
15:30

Reception and Networking

There is no charge for attendance but registration is required.  Seats are limited to end-users of bioprocessing tools and technologies.

Travel, accommodations, and incidental expenses are the responsibility of attendees.
Lunch will be served.

  

Omni La Costa Resort & Spa (Carlsbad)

2100 Costa Del Mar Road
Carlsbad, California 92009

  
 

REGISTER NOW


 
Scroll To Top